3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 26 0 0 0 0 0 0 0999 V2000
2.3958 0.8071 0.0005 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1977 -1.4994 0.0001 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.6244 1.2001 0.0009 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7872 -1.1731 -0.0009 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6819 -0.9121 1.2471 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6792 -0.9094 -1.2502 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2130 0.5511 1.2106 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2111 0.5534 -1.2111 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2874 -0.0963 0.0011 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2202 1.1469 0.0019 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7130 -0.3706 0.0007 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8233 0.7021 -0.0006 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3822 -2.1887 -0.0016 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.1099 -1.0730 2.1692 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.5256 -1.6119 1.2692 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.5225 -1.6096 -1.2761 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.1050 -1.0677 -2.1715 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.3081 0.5715 1.1693 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.9095 1.0936 2.1141 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.9067 1.0982 -2.1129 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.3063 0.5732 -1.1712 H 0 0 0 0 0 0 0 0 0 0 0 0
0.2836 2.1012 0.0027 H 0 0 0 0 0 0 0 0 0 0 0 0
4.2389 1.7132 -0.0008 H 0 0 0 0 0 0 0 0 0 0 0 0
4.1631 0.1816 -0.9010 H 0 0 0 0 0 0 0 0 0 0 0 0
4.1646 0.1812 0.8990 H 0 0 0 0 0 0 0 0 0 0 0 0
1 11 1 0 0 0 0
1 12 1 0 0 0 0
2 11 2 0 0 0 0
3 7 1 0 0 0 0
3 8 1 0 0 0 0
3 10 1 0 0 0 0
4 5 1 0 0 0 0
4 6 1 0 0 0 0
4 9 1 0 0 0 0
4 13 1 0 0 0 0
5 7 1 0 0 0 0
5 14 1 0 0 0 0
5 15 1 0 0 0 0
6 8 1 0 0 0 0
6 16 1 0 0 0 0
6 17 1 0 0 0 0
7 18 1 0 0 0 0
7 19 1 0 0 0 0
8 20 1 0 0 0 0
8 21 1 0 0 0 0
9 10 2 0 0 0 0
9 11 1 0 0 0 0
10 22 1 0 0 0 0
12 23 1 0 0 0 0
12 24 1 0 0 0 0
12 25 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
methyl 1-azabicyclo[2.2.2]oct-2-ene-3-carboxylate
4.2 InChl
InChI=1S/C9H13NO2/c1-12-9(11)8-6-10-4-2-7(8)3-5-10/h6-7H,2-5H2,1H3
4.3 InChlKey
SDEKJEJGZPSNFT-UHFFFAOYSA-N
4.4 Canonical SMILES
COC(=O)C1=CN2CCC1CC2
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病